Table 4

Hazard ratios (HRs) and 95% confidence intervals (CIs) of hepatocellular carcinoma (HCC) according to hepatitis C virus infection status and genotype
Anti-HCV HCV RNA HCV genotype No. of subjects No. of HCC Person-years Incidence (100,000 person-year) HRa(95% CI) HRb(95% CI)
Negative 6083 31 56,516.3 54.9 1.0 (reference) 1.0 (reference)
Positive Positive 1 52 8 476.5 1,678.9 28.3 (13.0-61.5) 29.7 (13.6-46.8)
2 84 1 850.7 117.6 2.1 (0.3-15.4) 2.2 (0.3-16.2)
1 & 2 6 2 51.1 3,913.9 65.0 (15.5-272.3) 68.7 (16.4-288.4)
Negative 109 2 1,045.2 191.4 3.4 (0.8-14.4) 2.6 (0.6-11.5)

aHR: age- and sex-adjusted. bHR: age-, sex- and HBsAg positivity-adjusted. Two hundred and thirty-six subjects including 2 HCC cases had no information on anti-HCV, and were excluded from the analysis.

Oh et al.

Oh et al. BMC Cancer 2012 12:452   doi:10.1186/1471-2407-12-452

Open Data